CT

EQS-News: Nagarro posts 12.9% YoY constant-currency revenue growth in 9M 2023

Retrieved on: 
Wednesday, December 6, 2023
GMT, SGT, EBITDA, CT, Net, GST, ET, PT, IST, EBIT, Organic, Q3, Growth, CET, Beauty salon, Flour, Entrepreneurship

In Q3 2023, revenue grew to €234.3 million, up 1.9% YoY from €229.8 million in Q3 2022 and up 6.6% YoY in constant currency.

Key Points: 
  • In Q3 2023, revenue grew to €234.3 million, up 1.9% YoY from €229.8 million in Q3 2022 and up 6.6% YoY in constant currency.
  • Adjusted EBITDA declined to €32.0 million (13.7% of revenue) in Q3 2023 from €48.4 million (21.1% of revenue) in Q3 2022.
  • Revenue grew to €690.6 million in 9M 2023, up 10.4% YoY from €625.4 million in 9M 2022.
  • Adjusted EBITDA declined to €92.4 million (13.4% of revenue) in 9M 2023 from €117.6 million (18.8% of revenue) in 9M 2022.

Fraser Institute News Release: Of 30 countries with universal health care, Canada among highest spenders, but ranks near the bottom for number of doctors, hospital beds, MRIs and has the longest wait times

Retrieved on: 
Thursday, November 9, 2023
Magnetic resonance, MRI, Policy, Fraser Institute, Public policy, Government, Magnetic resonance imaging, Research, Entrepreneurship, Quality of life, COVID-19, CT, Bangladesh Technical Education Board, Patient, Bed, Health insurance, Nursing

The study compares 30 universal health-care systems in developed countries, spotlighting several key areas including cost, availability and use of resources, access to care, clinical performance and quality.

Key Points: 
  • The study compares 30 universal health-care systems in developed countries, spotlighting several key areas including cost, availability and use of resources, access to care, clinical performance and quality.
  • In 2021, the latest year of comparable data, Canada’s health-care spending as a share of the economy (12.6 per cent) ranks highest (after adjusting for population age) and eighth highest for health care spending per capita.
  • Canada ranks 25th (out of 29) for the number of Magnetic Resonance Imaging (MRI) machines with 10.3 MRIs per million people, and 26th (out of 30) for CT scanners with 14.9 scanners per million people.
  • To protect the Institute’s independence, it does not accept grants from governments or contracts for research.

New Shockwave Coronary IVL Publication Shows Similar Outcomes in Women And Men

Retrieved on: 
Thursday, November 9, 2023
Yale School of Medicine, CAD, IV, Treatment, Coronary artery disease, Dissection, Doctor of Philosophy, IVL, Journal, St. Francis Hospital, TLF, MACE, HR, Perforation, CT, Woman, Safety, Society, USE, Hospital, Reflow soldering, EMPOWER, Cardiovascular disease, Pharmaceutical industry, Birth control, MD, Cardiology

The one-year results from Disrupt CAD III and IV trials were recently published in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI) .

Key Points: 
  • The one-year results from Disrupt CAD III and IV trials were recently published in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI) .
  • In the patient-level pooled analysis, titled “Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Lesions: Long-Term Sex-Specific Outcomes,” use of IVL for lesion preparation of severely calcified lesions had similar safety and effectiveness in women and men at a one-year follow-up.
  • At one-year, major adverse cardiovascular event (MACE) rates were not different between women and men (12.3% vs 13.2%, p=0.52) and there was no difference between women and men in target lesion failure (TLF, 10.4% vs. 11.2% p=0.43).
  • The European lead is Nieves Gonzalo, MD, PhD, Consultant Interventional Cardiologist at Hospital Clinico San Carlos in Madrid, Spain.

Olympus Corp. of the Americas to Host Panel Discussion on Lung Cancer Screening Guidelines and Eligibility

Retrieved on: 
Thursday, November 9, 2023
Canadian Lung Association, American Cancer Society, Temple University School of Medicine, Incidence, American Lung Association, Lung cancer, Physician, University College, Oxford, United, Critical care, Death, Scan, Disease, Risk, Luke the Evangelist, CT, Woman, Olympus, Cancer, Patient, OCA, Medical imaging, St Luke's

CENTER VALLEY, Pa., Nov. 9, 2023 /PRNewswire/ -- As part of Lung Cancer Awareness Month, Olympus Corp. of the Americas (OCA) and the American Lung Association are partnering to raise awareness around the importance of early detection and provide a better understanding of eligibility around lung cancer screening guidelines.

Key Points: 
  • CENTER VALLEY, Pa., Nov. 9, 2023 /PRNewswire/ -- As part of Lung Cancer Awareness Month, Olympus Corp. of the Americas (OCA) and the American Lung Association are partnering to raise awareness around the importance of early detection and provide a better understanding of eligibility around lung cancer screening guidelines.
  • The event, "Breathing Life into Lung Cancer Awareness," will look at the current state of lung cancer in the U.S. and highlight the importance of early detection.
  • Olympus and the Lung Association want to help people understand who is at risk for lung cancer, for whom a screening is recommended based on the updated U.S Preventive Services Task Force guidelines and what a screening involves.
  • Dr. Stahlnecker, a paid consultant for Olympus, will also address the importance of lung cancer staging once cancer is diagnosed.

RadNet Reports Third Quarter Financial Results and Revises Upwards 2023 Financial Guidance Range for Adjusted EBITDA

Retrieved on: 
Wednesday, November 8, 2023
Adjustment, MRI, De novo, Santa Claus, EBCD, RadNet, Consolidated Revenue Fund of Canada, EBITDA, Acquisition, Health, Debt, Artificial intelligence, Mammography, Growth, Partnership, LOS, CT, Workflow, Record, AI, PET/CT, Patient, Video game, Medical device, Bookkeeping, Hospital, Insurance, Cedars-Sinai Medical Center

Dr. Berger added, “I am very pleased to announce that during the quarter, we expanded our outpatient radiology partnership with Cedars-Sinai. This includes establishing a new joint venture called Los Angeles Imaging Group, initially with three locations, as well as broadening our existing three-center joint venture, Santa Monica Imaging Group, to include the contribution of seven additional centers -- five of which were contributed by Cedars-Sinai. The expanded relationship with Cedars-Sinai is designed to increase patient access to outpatient radiology by broadening the ambulatory network of imaging centers throughout Los Angeles, including certain underserved communities. The ventures will streamline and improve patient care by improving workflow, providing better access to records and producing more timely and accurate results for patients and referring physicians. After giving effect to the expanded Cedars-Sinai relationship, we now have almost 36% of our imaging centers held within health system partnerships.”

Key Points: 
  • Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented, “I am very pleased with our performance in the third quarter.
  • Our Imaging Center segment Adjusted EBITDA(1) increased 20.3% as compared with last year’s third quarter, which resulted in Imaging Center margin expansion from 14.4% in last year’s third quarter to 15.1% in this year’s same quarter.
  • As compared with last year’s third quarter, Revenue increased $49.9 million (or 14.3%) and Adjusted EBITDA(1) increased $10.2 million (or 20.3%).
  • For the third quarter of 2023, RadNet reported Net Income of $17.5 million as compared with $668,000 for the third quarter of 2022.

WELL Health Launches "WELL Longevity+" A Program Designed to Provide the Most Advanced Preventative Care Available

Retrieved on: 
Thursday, November 9, 2023
MRI, Genetic testing, WELL Health Technologies, Health, Heart, Longevity, Life, Age, Nature, Partnership, CT, WELL, Disability, Cancer, AI, Patient, Diagnosis, Death, TSX, Medical device, Medical imaging, Nursing

WELL Health announces the launch of the WELL Longevity+ Program, enhancing preventative health with advanced precision diagnostics and AI technologies for the early detection of serious health conditions.

Key Points: 
  • WELL Health announces the launch of the WELL Longevity+ Program, enhancing preventative health with advanced precision diagnostics and AI technologies for the early detection of serious health conditions.
  • Expansion plans include rolling out WELL Longevity+ services through WELL Health's network of preventative health clinics throughout Canada.
  • WELL Longevity+ is a progressive extension of its preventative health division and designed to redefine the future of personal and corporate wellness.
  • In fact, WELL strongly encourages all patients to share their preventative health recommendations with their family physician and/or primary care provider.

NexCore Group and Arizona Oncology Celebrate the Opening of New Cancer Center in Prescott, Arizona

Retrieved on: 
Wednesday, November 8, 2023
Science, Urology, McKesson Corporation, Surgical oncology, Breast cancer, CT, Cancer, LINAC, Patient, Google Images, HDR, Oncology, Hospital, Nursing, Medical imaging

DENVER, Nov. 8, 2023 /PRNewswire-PRWeb/ -- NexCore Group, a national healthcare, life sciences, and senior living real estate developer, celebrated the grand opening of a new cancer center October 27 serving the residents in Prescott, Arizona. Arizona Oncology, one of the largest medical groups in Arizona devoted exclusively to cancer care, and NexCore collaborated on the 23,000-square-foot facility which opened to the public in October 2023. The Arizona Oncology Cancer Center offers patients in the region convenient access to the latest cancer treatment services and technologies.

Key Points: 
  • The Arizona Oncology Cancer Center offers patients in the region convenient access to the latest cancer treatment services and technologies.
  • The Arizona Oncology Cancer Center offers patients in the region convenient access to the latest cancer treatment services and technologies.
  • "The Prescott community now has access to exceptional cancer care at the newly opened Arizona Oncology center, a project realized through the collaboration of NexCore Group with McKesson and US Oncology.
  • "The Prescott community now has access to exceptional cancer care at the newly opened Arizona Oncology center, a project realized through the collaboration of NexCore Group with McKesson and US Oncology", commented NexCore President Jarrod Daddis.

Lyra Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, November 7, 2023
Mometasone, Research, Food, Public expenditure, Polyp, Bronchitis, Regulation of tobacco by the U.S. Food and Drug Administration, Network congestion, Sinusitis, COVID-19, Common, New Drug Application, CT, Depreciation, Safety, CRS, MF, Therapy, Investment, Patient, LYRA, Nursing, Pharmaceutical industry, Medical device, Birth control, Lyra

WATERTOWN, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting anti-inflammatory therapies for the localized treatment of chronic rhinosinusitis (CRS), today reported its financial results for the third quarter ended September 30, 2023 and provided a corporate update.  

Key Points: 
  • The Company plans to submit results of the BEACON study for presentation at an upcoming medical meeting.
  • In August 2023, Lyra announced completion of enrollment in the pivotal Phase 3 ENLIGHTEN I clinical trial.
  • Cash, cash equivalents and short-term investments as of September 30, 2023 were $102.6 million, compared with $116.2 million at June 30, 2023.
  • Net loss for the quarter ended September 30, 2023 was $15.7 million compared to $14.8 million for the same period in 2022.

ACV Announces Participation in Upcoming Investor Conferences

Retrieved on: 
Tuesday, November 7, 2023
NASH, Conference, Webcast, CT, Cryptocurrency, Clothing

BUFFALO, N.Y., Nov. 07, 2023 (GLOBE NEWSWIRE) -- ACV (Nasdaq: ACVA), a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced today that members of its management team will present at the following upcoming investor conferences:

Key Points: 
  • BUFFALO, N.Y., Nov. 07, 2023 (GLOBE NEWSWIRE) -- ACV (Nasdaq: ACVA), a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced today that members of its management team will present at the following upcoming investor conferences:
    Stephens Annual Investment Conference (NASH 2023) on Thursday, November 16, 2023 at 9:00 a.m. CT
    Needham 3rd Annual Consumer Tech/E-Commerce Virtual Conference on Monday, November 20, 2023 at 12:00 p.m.
  • ET
    Webcasts of these events will be available on the Company’s investor relations website at https://investors.acvauto.com/ .
  • An archived replay of each webcast will be available following the live presentations.

Wolters Kluwer experts present webinar on preparing for upcoming Corporate Transparency Act rule

Retrieved on: 
Tuesday, November 7, 2023
Legal, Finance, Consulting, Banking, Small Business, Accounting, Professional Services, Fintech, Privacy Office of the U.S. Department of Homeland Security, Wolters Kluwer, FCC, EST, Financial Crimes Enforcement Network, CTA, CT Corporation, Risk management, BOI, CT, Wolters, UCC, Audit

Experts from Wolters Kluwer CT Corporation will offer insights in preparing for and complying with new “beneficial ownership” reporting requirements that go into effect January 1, 2024 in a webinar, “ Preparing for the Corporate Transparency Act .” The webinar takes place from 1-2 pm EST Wednesday, November 15.

Key Points: 
  • Experts from Wolters Kluwer CT Corporation will offer insights in preparing for and complying with new “beneficial ownership” reporting requirements that go into effect January 1, 2024 in a webinar, “ Preparing for the Corporate Transparency Act .” The webinar takes place from 1-2 pm EST Wednesday, November 15.
  • Wolters Kluwer presenters include CT Corporation’s Anirudh John , Product Management Associate Director, and Beverly Odom , Transactional Business Consultant.
  • For more than 130 years, Wolters Kluwer CT Corporation has been the leading provider of registered agent services, incorporation services, and legal entity compliance.
  • It is part of Wolters Kluwer’s Financial & Corporate Compliance (FCC) division and has a global reach into over 150 countries.